JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
Journal of Clinical Pathology 2007;60:104-106; doi:10.1136/jcp.2006.036715
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chim, C.-S.
Right arrow Articles by Kwong, Y.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chim, C.-S.
Right arrow Articles by Kwong, Y.-L.
Right arrowPubmed/NCBI databases
*Genetics Home Reference

SHORT REPORT

Aberrant gene methylation implicated in the progression of monoclonal gammopathy of undetermined significance to multiple myeloma

Chor-Sang Chim, Raymond Liang, Man-Hin Leung, Yok-Lam Kwong

University Department of Medicine, Queen Mary Hospital, Hong Kong

Correspondence to:
Dr C-S Chim
Department of Medicine, Queen Mary Hospital, Pokfulam Road, Hong Kong 852, Hong Kong; jcschim{at}hku.hk
ABSTRACT
Malignant transformation is a multistep process that may involve dysregulation of oncogenes and tumour suppressor genes, and monoclonal gammopathy of undetermined significance (MGUS) is believed to be a precursor of multiple myeloma. To investigate whether aberrant promoter methylation might be involved in the evolution of MGUS to multiple myeloma, we examined the p16, protein tyrosine phosphatase, non-receptor type 6 (SHP1), death-associated protein (DAP) kinase, E-cadherin and oestrogen receptor genes, most being tumour suppressor genes, by methylation-specific polymerase chain reaction. In 32 cases of multiple myeloma and 19 cases of MGUS, significantly more frequent methylation of p16 (p = 0.001), SHP1 (p<=0.001) and E-cadherin (p<=0.001) genes was found in multiple myeloma than in MGUS. Methylation of DAP kinase and oestrogen receptor genes was comparable in multiple myeloma and MGUS. In conclusion, methylation of p16, SHP1 and E-cadherin genes might be involved in the progression of MGUS to multiple myeloma.

Abbreviations: DAP, death-associated protein; MGUS, monoclonal gammopathy of undetermined significance; MSP, methylation-specific polymerase chain reaction; SHP1, protein tyrosine phosphatase, non-receptor type 6.




This article has been cited by other articles:


Home page
 J. Clin. Pathol.Home page
C.-S. Chim, R. Liang, T.-K. Fung, C.-L. Choi, and Y.-L. Kwong
Epigenetic dysregulation of the death-associated protein kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in multiple myeloma
J. Clin. Pathol., June 1, 2007; 60(6): 664 - 669.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.